PharmaShots Weekly Snapshot (April 27 -May 01, 2020)
Published: Apr 30, 2020 | Tags: WuXi Biologics, Aravive, Collaborate, Develop, Novel, High-Affinity Bispecific Antibodies, Cancer, Fibrosis
Published: May 01, 2020 | Tags: Novartis, Enerzair, Breezhaler, QVM149, IND/GLY/MF, Receives, CHMP, Recommendation, Approval, Treatment, Uncontrolled Asthma
?? Moderna Signs a Ten-Year Worldwide Agreement with Lonza to Manufacture mRNA-1273 Against COVID-19
Published: May 01, 2020 | Tags: Moderna, Signs, Ten-Year, Worldwide, Agreement, Lonza, Manufacture, mRNA-1273, Against, COVID-19
Pfizer Signs a Development and Commercialization Agreement with Valneva for Lyme Disease Vaccine
Published: Apr 30, 2020 | Tags: Pfizer, Signs, Development, Commercialization, Agreement, Valneva, Lyme Disease, Vaccine Candidate
Published: Apr 29, 2020 | Tags: MSD, Signs, Two-Year, Research Agreement, Almac, Discover, DUB Therapeutic Targets, Neurodegenerative Diseases
Bergenbios Bemcentinib Selected to be Fast-Tracked Under UKs ACCORD Program Targeting COVID-19
Published: Apr 23, 2020 | Tags: Bergenbio, Bemcentinib, Fast-Tracked, UK, ACCORD Program, Targeting, COVID-19
Published: Apr 29, 2020 | Tags: GSK, Zejula, niraparib, Receives, US, FDA, Approval, 1L, Monotherapy, Maintenance Treatment, Women, Advanced Ovarian Cancer, Biomarker Status
Published: Apr 30, 2020 | Tags: AstraZeneca, Signs, Worldwide, Development, Distribution, Agreement, Oxford University, Vaccine, Against, COVID-19
Gilead Reports Results of Remdesivir in P-III SIMPLE Studies for Patients with Severe COVID-19
Published: Apr 29, 2020 | Tags: Gilead, Reports, Results, Remdesivir, P-III, SIMPLE Studies, Patients, Severe COVID-19
Published: Apr 29, 2020 | Tags: Johnson & Johnson, Manufacturing Agreement, Catalent, Bolster, Capacity, COVID-19 Vaccine, US
Published: Apr 29, 2020 | Tags: Merck, Keytruda, pembrolizumab, Receives, US, FDA, Approval, Additional, Recommended Dose, 400 mg, Every Six Weeks, All Approved Indications
Published: Apr 28, 2020 | Tags: Novartis, Plans, Commence, P-III, Clinical Study, Evaluating, Canakinumab, Patients, COVID-19 Pneumonia
Published: Apr 29, 2020 | Tags: Astellas, Signs, Three Years, Research Alliance, Harvard University, Multiple Therapeutics Areas
BioNTech and Pfizer Complete Dosing of BNT162 in First Cohort of P-I/II Study in Germany
Published: Apr 22, 2020 | Tags: BioNTech, Pfizer, Completes, Dosing, First Cohort, P-I/II, Study, Evaluating, BNT162, Germany
Published: Apr 22, 2020 | Tags: Novartis, Cosentyx ,secukinumab, Receives, EC, Approval, Axial Spondyloarthritis Spectrum, Marking, Fourth Indication, EU
Published: Apr 28, 2020 | Tags: Sarepta, Signs, Research Agreement, US Department of Defense, Identify, Antisense Oligonucleotides, Against, COVID-19
??Biocon and Mylan Launch Fulphila (biosimilar, pegfilgrastim) in Canada
Published: Apr 28, 2020 | Tags: Biocon, Mylan, Launch, Fulphila, biosimilar, pegfilgrastim, Canada
Moderna to Initiate P-II Study of mRNA-1273 Against Novel COVID-19
Published: Apr 27, 2020 | Tags: Moderna, Initiate, P-II, Study, mRNA-1273, Against, COVID-19
Published: Apr 21, 2020 | Tags: Abbott, Freestyle Libre System, Receives, Health Canada Authorization, Under Interim Order, Hospitalized Patients, COVID-19
Published: Apr 27, 2020 | Tags: Takeda, Mobocertinib, TAK-788, Receives, US, FDA, Breakthrough Therapy Designation, NSCLC, Patients, EGFR Exon 20 Insertion Mutations
CEPI Collaborates with Clover to Support the Development of Vaccine Against COVID-19 in Australia
Published: Apr 27, 2020 | Tags: CEPI, Collaborates, Clover, Support, Development of Vaccine, COVID-19, Australia
Published: Apr 28, 2020 | Tags: Roche, PTC Therapeutics, Report, Results, Risdiplam, FIREFISH Part 2, Study, Infants, Type 1 Spinal Muscular Atrophy
Published: Apr 27, 2020 | Tags: Merck, Collaborates, ISB, Evaluate, Mechanism of COVID-19, Identify, Potential, Prognostic Biomarkers
?Capital Health Launches Antibody Testing Initiative for COVID-19
Published: Apr 27, 2020 | Tags: Capital Health, Launches, Antibody Testing Initiative, COVID-19
Published: Apr 27, 2020 | Tags: Otsuka, Signs, Development, Commercialization, Agreement, Esperion, Nexletol, bempedoic acid, Nexlizet, bempedoic acid and ezetimibe, Japan
Published: Apr 24, 2020 | Tags: Chugai, Reports, Results, SAkuraStar, Satralizumab, NOSD
Published: Apr 24, 2020 | Tags: Janssen, sBLA, US FDA, SIMPONI ARIA, Polyarticular Juvenile Idiopathic Arthritis, Juvenile Psoriatic Arthritis
Published: Apr 27, 2020 | Tags: Santhera, Signs, Clinical Trial Agreement, Cold Spring Harbor Laboratory, Evaluate, Lonodelestat, (POL6014), Against, Acute Respiratory Distress Syndrome Associated, COVID-19
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com